Mateo, J., Castro, E., Zacchi, F., Medina, M. I. S., Imbach, K., Rodriguez-Vida, A., Arnau, G. M., Mellado, B., Simonetti, S., Gauna, D. C., Duran, M. A. C., Borque-Fernando, Ã., Pous, A. F., Guerrero-Martinez, J. A., Izquierdo, V., Perez-Escuredo, J., Gonzalez-Alonso, P., Porta, E., Zurita, A. J., Carles, J. (2026). Final results from ZZFIRST: A randomized phase 2 trial of enzalutamide (EZ) and talazoparib (TALA) in metastatic hormone-naïve prostate cancer (mHNPC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5006